Detalhe da pesquisa
1.
Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.
Br J Clin Pharmacol
; 88(1): 260-270, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182611
2.
AZD5634, an inhaled ENaC inhibitor, in healthy subjects and patients with cystic fibrosis.
J Cyst Fibros
; 21(4): 684-690, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227647
3.
Diurnal variation in DLCO and non-standardized study procedures may cause a false positive safety signal in clinical trials.
Respir Med
; 191: 106705, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879298
4.
Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung - a test-retest PET study in control subjects.
EJNMMI Res
; 10(1): 59, 2020 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495011
5.
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Int J Chron Obstruct Pulmon Dis
; 13: 1009-1019, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29628759